Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases: Castle of Rauischholzhausen of the Justus-Liebig-University, Giessen, Germany, March 18-19, 2005

Journal of the Pancreas

Volumn 6, Issue 4, 2005, Pages 382-405

  Andren Sandberg, Åke ^a   Hardt, Philip D ^b  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Autoimmunity; Congresses; Diabetes mellitus; Islets of Langerhans; Pancreas, exocrine; Pancreatitis

Indexed keywords

AUTOIMMUNITY; CHRONIC PANCREATITIS; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GERMANY; HEALTH PRACTITIONER; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS DISEASE; PANCREAS INSUFFICIENCY; PANCREAS ISLET; PATHOPHYSIOLOGY; PREVALENCE; TISSUE INTERACTION; WORKSHOP; AUTOIMMUNE DISEASE; CHRONIC DISEASE; HUMAN; IMMUNOLOGY; PANCREAS; PANCREAS EXOCRINE INSUFFICIENCY; PANCREATITIS; PATHOLOGY;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHRONIC DISEASE; DIABETES COMPLICATIONS; EXOCRINE PANCREATIC INSUFFICIENCY; GERMANY; HUMANS; ISLETS OF LANGERHANS; PANCREAS; PANCREAS, EXOCRINE; PANCREATIC DISEASES; PANCREATITIS;

EID: 27244445158     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (137)

1. Rufus D'Éphèse. Oeuvres de Rufus d'Éphèse. Paris, France: Imprimerie Nationale, 1879.
2. Andreas Vesalius. De Humani Corporis Fabrica. Libri Septem. 1st Ed. Basel, Switzerlad: 1543.
3. Howard JM, Hess W, Traverso W. Johann Georg Wirsung (1589-1643) and the pancreatic duct: the prosector of Padua, Italy. J Am Coll Surg 1998; 187:201-11.
4. Giovanni Domenico Santorini. Observationes anatomicae. Venetiis, 1725
5. Frederik Ruysch. Opera omnia anatomico-medico-chirurgica, huc usque edita. Amstelodami: Apud Janssonio-Waesbergios, 1737.
6. Oddi R. Di una speciale disposizione a sfintere allo sbocco del coledoco. Arch Ital Biol 1887; 8:317-22.
7. Regnerus De Graaf. Tractatus anatomico-medicus de succi pancreatici. Amsterdam, 1671.
8. Johann C Brunner. Experimenta nova circa pancreas. Amsterdam, 1682.
9. Claude Bernard. Memoire sur le pancreas. Paris, France, 1856.
10. von Mering J, Minkowski O. Diabetes mellitus nach Pankreasexstirpation. Archiv für experimentelle Pathologie und Pharmakologie 1890; 26:371-87.
11. Langerhans P. Beitrage zur Mikroskopischen Anatomie der Bauchspeicheldruse. Doctoral dissertation. Berlin, 1869.
12. Laguesse E. Sur la formation des ilots de Langerhans dans le pancréas. Comptes Rendus Hebdomadaires Des Seances Et Memoires De La Societe De Biologie 1893; 5:819-20.
13. Banting FG, Best CH. Pancreatic extracts. J Lab Clin Med 1922; 7:464-72.
14. Macleod JJR. The source of insulin. A study of the effect produced on blood sugar by extracts of the pancreas and principal islets of fishes. J Metab Res 1922; 2:149-72.
15. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 1998; 339:653-8.
16. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998; 339:645-52.
17. Dani R, Antunes LJ, Rocha WM, Nogueira CE. AW23 and AW24 associated with chronic calcifying pancreatitis of alcoholic origin. Arq Gastroenterol 1978; 15:163-6.
18. Gosselin M, Fauchet R, Genetet B, Gastard J. HLA A and B antigens in chronic alcoholic pancreatitis. Gastroenterol Clin Biol 1978; 2:883-6.
19. Fauchet R, Genetet B, Gosselin M, Gastard J. HLA antigens in chronic alcoholic pancreatitis. Tissue Antigens 1979; 13:163-6.
20. Low M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H. Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung (ESTHER-Studie) [Epidemiological investigations of the chances of preventing, recognizing early and optimally treating chronic diseases in an elderly population (ESTHER study)]. Dtsch Med Wochenschr 2004; 129:2643-7.
21. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120:682-707.
22. Bordalo O, Goncalves D, Noronha M, Cristina ML, Salgadinho A, Dreiling DA. Newer concept for the pathogenesis of chronic alcoholic pancreatitis. Am J Gastroenterol 1977; 68:278-85.
23. Braganza JM, Wickens DG, Cawood P, Dormandy TL. Lipid-peroxidation (free-radical-oxidation) products in bile from patients with pancreatic disease. Lancet 1983; 2:375-9.
24. Sarles H. Etiopathogenesis and definition of chronic pancreatitis. Dig Dis Sci 1986; 31(9 Suppl):91S-107S.
25. Multigner L, Sarles H, Lombardo D, De Caro A. Pancreatic stone protein. II. Implication in stone formation during the course of chronic calcifying pancreatitis. Gastroenterology 1985; 89:387-91.
26. De Reggi M, Gharib B, Patard L, Stoven V. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals. J Biol Chem 1998: 273:4967-71,
27. Schmiegel W, Burchert M, Kalthoff H, Roeder C, Butzow G, Grimm H, et al. Immunochemical characterization and quantitative distribution of pancreatic stone protein in sera and pancreatic secretions in pancreatic disorders. Gastroenterology 1990; 99:1421-30.
28. Cavallini G, Bovo P, Bianchini E, Carsana A, Costanzo C, Merola M, et al. Lithostathine messenger RNA expression in different types of chronic pancreatitis. Mol Cell Biochem 1998; 185:147-52.
29. Matozaki T, Sakamoto C, Suzuki T, Chujo S, Matsuda K, Wada K, et al. Idiopathic chronic calcifying pancreatitis with diabetes mellitus. Analysis of pancreatic stone protein gene. Dig Dis Sci 1993; 38:963-7.
30. Schiesser M, Bimmler D, Frick TW, Graf R. Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates. Pancreas 2001; 22:186-92.
31. Kobayashi S, Akiyama T, Nata K, Abe M, Tajima M, Shervani NJ, et al. Identification of a receptor for reg (regenerating gene) protein, a pancreatic beta-cell regeneration factor. J Biol Chem 2000; 275:10723-6.
32. Luttenberger T, Schmid-Kotsas A, Menke A, Siech M, Beger H, Adler G, et al. Platelet-derived growth factors stimulate proliferation and extracellular matrix synthesis of pancreatic stellate cells: implications in pathogenesis of pancreas fibrosis. Lab Inves 2000; 80:47-55.
33. Apte MV, Haber PS, Darby SJ, Rodgers SC, McCaughan GW, Korsten MA, et al. Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis. Gut 1999; 44:534-41.
34. Van Laethem JL, Marchant A, Delvaux A, Goldman M, Robberecht P, Velu T, Deviere J. Interleukin 10 prevents necrosis in murine experimental acute pancreatitis. Gastroenterology 1995; 108:1917-22.
35. Vogelmann R, Ruf D, Wagner M, Adler G, Menke A. Effects of fibrogenic mediators on the development of pancreatic fibrosis in a TGF-beta1 transgenic mouse model. Am J Physiol Gastrointest Liver Physiol 2001; 280:G164-72.
36. Van Laethem JL, Robberecht P, Resibois A, Deviere J. Transforming growth factor beta promotes development of fibrosis after repeated courses of acute pancreatitis in mice. Gastroenterology 1996; 110:576-82.
37. Dominguez-Munoz JE, ed. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Malden, MA, USA: Blackwell Publishing Ltd, 2005. [ISBN 978-1-4051-2276-4]
38. Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952; 21:54-63.
39. Smithies AM, Sargen K, Demaine AG, Kingsnorth AN. Investigation of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 2000; 20:234-40.
40. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001; 129:633-40.
41. Sargen K, Demaine AG, Kingsnorth AN. Cytokine gene polymorphisms in acute pancreatitis. JOP. J Pancreas (Online) 2000; 1:24-35.
42. Zhang H, Li Y, Wang S, Zhang K, Li L, Wu X. LPS-induced NF-kappa B activation requires Ca2+ as a mediator in isolated pancreatic acinar cells of rat. Chin Med J (Engl) 2003; 116:1662-7.
43. Dianliang Z, Jieshou L, Zhiwei J, Baojun Y. Association of plasma levels of tumor necrosis factor (TNF)-alpha and its soluble receptors, two polymorphisms of the TNF gene, with acute severe pancreatitis and early septic shock due to it. Pancreas 2003; 26:339-43.
44. Balog A, Gyulai Z, Boros LG, Farkas G, Takacs T, Lonovics J, Mandi Y. Polymorphism of the TNF-alpha, HSP70-2, and CD14 genes increases susceptibility to severe acute pancreatitis. Pancreas 2005; 30:e46-50.
45. Chowdhury RS, Forsmark CE, Davis RH, Toskes PP, Verne GN. Prevalence of gastroparesis in patients with small duct chronic pancreatitis. Pancreas 2003; 26:235-8.
46. Japan Pancreas Society. Diagnostic criteria for autoimmune pancreatitis by the Japan Pancreas Society (2002). J Jpn Pancreas Soc 2002; 17:585-7.
47. Tanaka S, Kobayashi T, Momotsu T. A novel subtype of type 1 diabetes mellitus. N Engl J Med 2000; 342:1835-7.
48. Smith CD, Behrns KE, van Heerden JA, Sarr MG. Radical pancreatoduodenectomy for misdiagnosed pancreatic mass. Br J Surg 1994; 81:585-9.
49. Van Gulik TM, Reeders JW, Bosma A, Moojen TM, Smits NJ, Allema JH, et al. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997; 46:417-23.
50. Abraham SC, Wilentz RE, Yeo CJ, Sohn TA, Cameron JL, Boitnott JK, Hruban RH. Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'? Am J Surg Pathol 2003; 27:110-20.
51. Thal AP, Murray MJ, Egner W. Isoantibody formation in chronic pancreatic disease. Lancet 1959; 1:1128-9.
52. Sarles H, Sarles JC, Muratore R, Guien C. Chronic inflammatory sclerosis of the pancreas - an autonomous pancreatic disease? Am J Dig Dis 1961; 6:688-98.
53. Sarles H, Sarles JC, Camatte R, Muratore R, Gaini M, Guien C, et al. Observations on 205 confirmed cases of acute pancreatitis, recurring pancreatitis, and chronic pancreatitis. Gut 1965; 6:545-59.
54. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344:732-8.
55. Hahm KB, Im YH, Lee C, Parks WT, Bang YJ, Green JE, Kim SJ. Loss of TGF-beta signaling contributes to autoimmune pancreatitis. J Clin Invest 2000; 105:1057-65.
56. Okazaki K, Chiba T. Autoimmune related pancreatitis. Gut 2002; 51:1-4
57. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986; 29:267-74.
58. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 2001; 345:1036-40.
59. Diabetes Prevention Trial, Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes mellitus. N Engl J Med 2002; 346:1685-91.
60. Gale EA, Bingley PJ, Emmett CL, Collier T, European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 2004; 363:925-31.
61. Seyrig JA, Jian R, Modigliani R, Golfain D, Florent C, Messing B, Bitoun A. Idiopathic pancreatitis associated with inflammatory bowel disease. Dig Dis Sci 1985; 30:1121-6.
62. Lankisch PG, Schmidt I, Konig H, Lehnick D, Knollmann R, Lohr M, Liebe S. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42:551-4.
63. Taniguchi T, Okazaki K, Okamoto M, Seko S, Tanaka J, Uchida K, et al. High prevalence of autoantibodies against carbonic anhydrase II and lactoferrin in type 1 diabetes: concept of autoimmune exocrinopathy and endocrinopathy of the pancreas. Pancreas 2003; 27:26-30.
64. Waguri M, Hanafusa T, Itoh N, Miyagawa J, Imagawa A, Kuwajima M, et al. Histopathologic study of the pancreas shows a characteristic lymphocytic infiltration in Japanese patients with IDDM. Endocr J 1997; 44:23-33.
65. Logsdon CD. Stimulation of pancreatic acinar cell growth by CCK, epidermal growth factor, and insulin in vitro. Am J Physiol 1986; 251(4 Pt 1):G487-94.
66. Kanno T, Saito A. The potentiating influences of insulin on pancreozymin-induced hyperpolarization and amylase release in the pancreatic acinar cell. J Physiol 1976; 261:505-21.
67. Singh M. Effect of endorphins on amylase secretion from rat pancreas in vivo and in vitro. Dig Dis Sci 1985; 30:257-62.
68. Matsushita K, Okabayashi Y, Koide M, Hasegawa H, Otsuki M, Kasuga M. Potentiating effect of insulin on exocrine secretory function in isolated rat pancreatic acini. Gastroenterology 1994; 106:200-6.
69. Singh J, Adeghate E, Salido GM, Pariente JA, Yago MD, Juma LO. Interaction of islet hormones with cholecystokinin octapeptide-evoked secretory responses in the isolated pancreas of normal and diabetic rats. Exp Physiol 1999; 84:299-318.
70. Singh J, Adeghate E. Effects of islet hormones on nerve-mediated and acetylcholine-evoked secretory responses in the isolated pancreas of normal and diabetic rats. Int J Mol Med 1998; 1:627-34.
71. Duan RD, Wicker C, Erlanson-Albertsson C. Effect of insulin administration on contents, secretion, and synthesis of pancreatic lipase and colipase in rats. Pancreas 1991; 6:595-602.
72. Ferrer R, Medrano J, Diego M, Calpena R, Graells L, Molto M, et al. Effect of exogenous insulin and glucagon on exocrine pancreatic secretion in rats in vivo. Int J Pancreatol 2000; 28:67-75.
73. Lam WF, Gielkens HA, Coenraad M, Souverijn JH, Lamers CB, Masclee AA. Effect of insulin and glucose on basal and cholecystokinin-stimulated exocrine pancreatic secretion in humans. Pancreas 1999; 18:252-8.
74. Layer P, Peschel S, Schlesinger T, Goebell H. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 1990; 258(2 Pt 1):G196-201.
75. Edlund H. Pancreatic organogenesis: developmental mechanisms and implications for therapy. Nat Rev Genet 2002; 3:524-32.
76. Lohr M, Kloppel G. Pathology of the pancreas in chronic type 1 diabetes mellitus: B-cell content, exocrine atrophy and angiopathy. Verh Dtsch Ges Pathol 1987; 71:114-9.
77. Gilbeau JP, Poncelet V, Libon E, Derue G, Heller FR. The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients. AJR Am J Roentgenol 1992; 159:527-31.
78. Alzaid A, Aideyan O, Nawaz S. The size of the pancreas in diabetes mellitus. Diabet Med 1993; 10:759-63.
79. Silva ME, Vezozzo DP, Ursich MJ, Rocha DM, Cerri GG, Wajchenberg BL. Ultrasonographic abnormalities of the pancreas in IDDM and NIDDM patients. Diabetes Care 1993; 16:1296-7.
80. Lazarus SS, Volk BW. Pancreas in maturity-onset diabetes. Pathogenetic considerations. Arch Pathol 1961; 71:44-59.
81. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14:619-33.
82. Kloppel G, Clemens A. Insulin-dependent diabetes mellitus. Current aspects of morphology, etiology and pathogenesis. Pathologe 1996; 17:269-75.
83. Foulis AK, McGill M, Farquharson MA, Hilton DA. A search for evidence of viral infection in pancreases of newly diagnosed patients with IDDM. Diabetologia 1997; 40:53-61.
84. Imagawa A, Hanafusa T, Miyagawa J, Matsuzawa Y. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med 2000; 342:301-7.
85. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, et al. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 2001; 50:1269-73.
86. Warren S, LeCompte PM. The Pathology of Diabetes Mellitus. Philadelphia, PA, USA: Lea and Iger, 1952.
87. Hardt PD, Krauss A, Bretz L, Porsch-Ozcurumez M, Schnell-Kretschmer H, Maser E, et al. Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 2000; 37:105-10.
88. Hardt PD, Hauenschild A, Nalop J, Marzeion AM, Jaeger C, Teichmann J, Bretzel RG, et al. High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients. Pacreatology 2003; 3:395-402.
89. Icks A, Haastert B, Giani G, Rathmann W, Low fecal elastase-1 in type I diabetes mellitus. Z Gastroenterol 2001; 39:823-30.
90. Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J, et al. Low faecal elastase 1 concentrations in type 2 diabetes mellitus. Scand J Gastroenterol 2001; 36:1056-61.
91. Luth S, Teyssen S, Forssmann K, Kolbel C, Krummenauer F, Singer MV. Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests? Scand J Gastroenterol 2001; 36:1092-9.
92. Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT. Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol 2001; 36:771-4.
93. Carroccio A, Verghi F, Santini B, Lucidi V, Iacono G, Cavataio F, et al. Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italian Society of Pediatric Gastroenterology and Hepatology. Dig Dis Sci 2001; 46:1335-42.
94. Walkowiak J, Herzig KH. Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest 2001; 31:425-30.
95. Hahn JU, Bochnig S, Kerner W, Koenig H, Sporleder B, Lankisch PG, et al. A new fecal elastase 1 test using polyclonal antibodies for the detection of exocrine pancreatic insufficiency. Pancreas 2005; 30;189-91.
96. Williams JA, Goldfine ID. The insulin-pancreatic acinar axis. Diabetes 1985; 34:980-6.
97. Korc M. Islet growth factors: curing diabetes and preventing chronic pancreatitis? J Clin Invest 1993; 92:1113-4.
98. Adler G, Kern HF. Regulation of exocrine pancreatic secretory process by insulin in vivo. Horm Metab Res 1975; 7:290-6.
99. el Newihi H, Dooley CP, Saad C, Staples J, Zeidler A, Valenzuela JE. Impaired exocrine pancreatic function in diabetics with diarrhea and peripheral neuropathy. Dig Dis Sci 1988; 33:705-10.
100. Vacca JB, Henke WJ, Knight WA Jr. the exocrine pancreas in diabetes mellitus. Ann Intern Med 1964; 61:242-7.
101. Volk BW, Lazarus SS. The effect of various diabetogenic hormones on the structure of the rabbit pancreas. Am J Pathol 1958; 34:121-35.
102. Dyck WP, Rudick J, Hoexter B, Janowitz HD. Influence of glucagon on pancreatic exocrine secretion. Gastroenterology 1969; 56:531-7.
103. Unger RH, Aguilar-Parada E, Muller WA, Eisentraut AM. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 1970; 49:837-48.
104. Patel YC, Weir GC. Increased somatostatin content of islets from streptozotocin-diabetic rats. Clin Endocrinol (Oxf) 1976; 5:191-4.
105. Tully GT, Lowenthall JJ. The diabetic coma of acute pancreatitis. Ann Intern Med 1958; 48:310-9.
106. Gamble DR. Viral and epidemiological studies. Proc R Soc Med 1975; 68:256-8.
107. Kobayashi T, Nakanishi K, Kajio H, Morinaga S, Sugimoto T, Murase T, Kosaka K. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33:363-70.
108. Sanvito F, Nichols A, Herrera PL, Huarte J, Wohlwend A, Vassalli JD, Orci L. TGF-beta 1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-alpha, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 1995; 217:1279-86.
109. Mally MI, Cirulli V, Hayek A, Otonkoski T. ICA69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia 1996; 39:474-80.
110. Perfetti R, Wang Y, Shuldiner AR, Egan JM. Molecular investigation of age-related changes in mouse endocrine pancreas. J Gerontol A Biol Sci Med Sci 1996; 51:B331-6.
111. Aarnes M, Schonberg S, Grill V. Fatty acids potentiate interleukin-1 beta toxicity in the beta-cell line INS-1E. Biochem Biophys Res Commun 2002; 296:189-93.
112. Warren KW, Fallis LS, Barron J. Acute pancreatitis and diabetes. Ann Surg 1950; 132:1103-10.
113. Scuro LA. Clinical classification of pancreatitis. Ric Clin Lab 1984; 14:361-5.
114. Bank S, Marks IN, Vinik AI. Clinical and hormonal aspects of pancreatic diabetes. Am J Gastroenterol 1975; 64:13-22.
115. Alberti KGMM. Diabetes secondary to pancreatopathy: an example of brittle diabetes. In: Tiengo A, Alberti KGMM, DelPrato S, Vranic M, eds. Diabetes Secondary to Pancreatopathy. International Congress Series 762. Amsterdam, The Netherlands: Excerpta Medica, 1988.
116. Günther O. Zur Ätiologie des Diabetes mellitus. Berlin, Germany: Akademie-Verlag, 1961.
117. Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, et al. Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol 1994; 89:762-6.
118. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klor HU. Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology 2002; 2:30-3.
119. Gullo L, Fontana G, Costa PL, Bolondi L, Ventrucci M, Caletti GC, et al. Etiopathogenetic aspects of chronic pancreatitis. Minerva Med 1977 16; 68:2057-61.
120. Anderson RJ, Dyer PA, Donnai D, Klouda PT, Jennison R, Braganza JM. Chronic pancreatitis, HLA and autoimmunity. Int J Pancreatol 1988; 3:83-90.
121. Blumenthal HT, Probstein JG, Berns AW. Interrelationship of Diabetes MellitusaAnd Pancreatitis Arch Surg 1963; 87:844-50.
122. Olsen TS. The incidence and clinical relevance of chronic inflammation in the pancreas in autopsy material. Acta Pathol Microbiol Scand [A] 1978; 86A:361-5.
123. Hardt PD, Hauenschild A, Jaeger C, Teichmann J, Bretzel RG, Kloer HU; S2453112/S2453113 Study Group. High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study. Dig Dis Sci 2003; 48:1688-92.
124. O'Keefe SJ, Cariem AK, Levy M. The exacerbation of pancreatic endocrine dysfunction by potent pancreatic exocrine supplements in patients with chronic pancreatitis. J Clin Gastroenterol 2001; 32:319-23.
125. Mohan V, Poongothai S, Pitchumoni CS. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int J Pancreatol 1998; 24:19-22.
126. Glasbrenner B, Malfertheiner P, Kerner W, Scherbaum WA, Ditschuneit H. Effect of pancreatin on diabetes mellitus in chronic pancreatitis. Z Gastroenterol 1990; 28:275-9.
127. Ebert R, Creutzfeldt W. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 1980; 19:198-204.
128. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 2002; 143:4397-408.
129. Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci 1983; 28:97-102.
130. Slaff J, Jacobson D, Tillman CR, Curington C, Toskes P. Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 1984; 87:44-52.
131. Halgreen H, Pedersen NT, Worning H. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 1986; 21:104-8.
132. Mossner J, Secknus R, Meyer J, Niederau C, Adler G. Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion 1992; 53:54-66.
133. Malesci A, Mariani A, Mezzi G, Bocchia P, Basilico M. New enteric-coated high-lipase pancreatic extract in the treatment of pancreatic steatorrhea. J Clin Gastroenterol 1994; 18:32-5.
134. Pollard H, Miller L, Brewer W. External secretion of the pancreas in diabetes (study of secretin test). Am J Dig Dis 1943; 10:20.
135. Chey WY, Shay H, Shuman CR. External pancreatic secretion in diabetes mellitus. Ann Intern Med 1963; 59:812-21.
136. Frier BM, Saunders JH, Wormsley KG, Bouchier IA. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 1976; 17:685-91.
137. Lankisch PG, Manthey G, Otto J, Koop H, Talaulicar M, Willms B, Creutzfeldt W. Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 1982; 25:211-6.